Insiders who reported open-market trades in the last 12 months at the companies Mark S. Ordan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
David M. Rubenstein - $40.44M in CG purchases and sales in the last 12 months
Shirley A. Weis - $856K in MD purchases and sales in the last 12 months
Michael A. Rucker - $241K in MD purchases and sales in the last 12 months
Laura A. Linynsky - $217K in MD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Mark S. Ordan is a corporate insider, tracked as Chief Executive Officer of Pediatrix Medical Group, Inc. (MD). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Mark S. Ordan last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 7 filings going back to 2024.
Has Mark S. Ordan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($939K) across all tracked filings.
Mark S. Ordan is Chief Executive Officer of Pediatrix Medical Group, Inc. (MD). 7 SEC Form 4 filings on record going back to 2024, most recently on 3 June 2026. Most recent open-market trade: sold $515K of MD on 17 December 2025. Lifetime open-market sales: $939K.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by Mark S. Ordan.
InsiderAlpha's records for Mark S. Ordan go back to 2024: 7 primary Form 4 filings, an average of 2.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
